{"id":"refresh-tears-0-5-lubricant-eye-drops","safety":{"commonSideEffects":[{"rate":null,"effect":"Transient blurred vision"},{"rate":null,"effect":"Eye irritation"},{"rate":null,"effect":"Ocular discomfort"}]},"_chembl":{"chemblId":"CHEMBL2158907","moleculeType":"Small molecule","molecularWeight":"404.60"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This product contains carboxymethylcellulose sodium 0.5%, a lubricating agent that mimics the viscous component of natural tears. It forms a protective film over the cornea and conjunctiva, reducing friction and evaporation while providing sustained moisture to the ocular surface. This mechanical lubrication alleviates discomfort associated with dry eye disease.","oneSentence":"Refresh Tears provides ocular lubrication by supplementing natural tear film to relieve dry eye symptoms.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:37:00.443Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Dry eye disease / Keratoconjunctivitis sicca"},{"name":"Ocular irritation and discomfort"}]},"trialDetails":[{"nctId":"NCT05292755","phase":"PHASE4","title":"Effects of Carboxymethylcellulose Artificial Tears on the Eye Microbiome","status":"COMPLETED","sponsor":"University of Florida","startDate":"2022-04-22","conditions":"Dry Eye Syndromes","enrollment":80},{"nctId":"NCT04843839","phase":"PHASE2","title":"CHED - Congenital Hereditary Endothelial Dystrophy: New Paradigm Shift in Therapy Using Topical Eye Drops","status":"UNKNOWN","sponsor":"L.V. Prasad Eye Institute","startDate":"2020-12-15","conditions":"Congenital Hereditary Endothelial Dystrophy of Cornea","enrollment":30},{"nctId":"NCT01346371","phase":"PHASE4","title":"The Effect of BEPREVE 1.5% on Tear Film Osmolarity and Tear Film Lipid Layer","status":"COMPLETED","sponsor":"Minnesota Eye Consultants, P.A.","startDate":"2011-05","conditions":"Allergic Conjunctivitis","enrollment":40},{"nctId":"NCT02007174","phase":"","title":"Bevacizumab Injection for Recurrent Pterygium","status":"COMPLETED","sponsor":"Instituto de Oftalmología Fundación Conde de Valenciana","startDate":"2012-03","conditions":"Recurrent Pterygium","enrollment":38},{"nctId":"NCT00485108","phase":"NA","title":"Anti-inflammatory Therapy Following Selective Laser Trabeculoplasty","status":"COMPLETED","sponsor":"Queen's University","startDate":"2007-01","conditions":"Primary Open Angle Glaucoma, Pseudoexfoliation Glaucoma","enrollment":120}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Carboxy-methylcellulose sodium lubricant eye drops 0.5%w/v"],"phase":"marketed","status":"active","brandName":"Refresh Tears 0.5% Lubricant Eye Drops","genericName":"Refresh Tears 0.5% Lubricant Eye Drops","companyName":"Minnesota Eye Consultants, P.A.","companyId":"minnesota-eye-consultants-p-a","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Refresh Tears provides ocular lubrication by supplementing natural tear film to relieve dry eye symptoms. Used for Dry eye disease / Keratoconjunctivitis sicca, Ocular irritation and discomfort.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}